Jagsonpal Pharmaceuticals Limited has announced an internal reshuffle at the senior-management level, elevating two long-standing executives to designated senior roles as of July 29, 2026. The leadership move underscores the company’s emphasis on strengthening IT governance and regulatory excellence from within, signaling a continuity-driven approach to translating digital and compliance ambitions into day-to-day operations.
Balmukund Keshav has been named Deputy General Manager (Information Technology). An MBA in Information Systems with over 29 years in IT leadership, he has spent 17 years at Jagsonpal steering digital transformations, ERP implementations, ITGC audits, and enterprise infrastructure management. His remit covers IT governance, risk management, information security, vendor management, and digital process automation, positioning Jagsonpal to push further on a secure, integrated technology backbone.
Sanjay Singhal has been designated General Manager (CQA & Regulatory Affairs). A pharmacy professional with a Master’s in Pharmaceutical Science from BITS Pilani, he brings 31 years of experience across manufacturing, supply chain, quality, and regulatory affairs. With Jagsonpal since March 2020, Singhal also serves as a government-approved technical person for all dosage forms across manufacturing and analytical divisions, underscoring a robust bridge between production excellence and regulatory compliance.
Taken together, the moves signal Jagsonpal’s intent to deepen leadership in two critical domains—information technology and regulatory quality. As pharma players navigate heightened digital demands and tighter oversight, internal appointments like these often help preserve institutional knowledge while accelerating core capabilities. In a sector where speed, data integrity, and compliance converge, the company appears to be betting on experienced practitioners who know the business from the inside to steer its next phase.